CRISP / AIO-TRK-0315: Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

Clinical Research Platform into Molecular Testing, Treatment, Outcome (CRISP): A Prospective German Registry in Stage IV NSCLC AIO-TRK-0315.

Study-ID: NCT02622581

DZL Disease Area: LC

Study Type: Observational

DZL Role: DZL recruiting center

Funding: Externally - industry

DZL Participating Sites: CPC-M

Start Date: 01.01.2018

Completion Date: 31.12.2027

Status: Recruiting

Disease: NSCLC

NCT Number: NCT02622581